研究团队
阮慧瞳


取得成果:

1.发表文章

1) H Ruan#; Q Hu#; D Wen; Q Chen; G Chen; Y Lu; J Wang; H Cheng; W Lu*; Z Gu*; A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade, Advanced Materials, 2019, 31(17): 1806957.

2) H Ruan#; Z Chai#; Q Shen; X Chen; B Su; C Xie; C Zhan; S Yao; H Wang; M Zhang; M Ying; W Lu*; A Novel Peptide Ligand RAP12 of LRP1 for Glioma Targeted Drug Delivery, Journal of Controlled Release, 2018, 279: 306-315.

3) H Ruan#; X Chen#; C Xie; B Li; M Ying; Y Liu;

M Zhang; X Zhang; C Zhan; W Lu; W Lu*; Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple Barriers, ACS Applied Materials & Interfaces, 2017, 9(21): 17745-17756.

4) H Ruan; L Bu; Q Hu; H Cheng; W Lu*; Z Gu*; Strategies of Combination Drug Delivery for Immune Checkpoint Blockades, Advanced Healthcare Materials, 2019, 8(4): 1801099.

2.主持科研项目:

1)第66批博士后科学基金(2019M661546,2020.01-2022.12,8万,在研)

2)第5批博士后创新人才支持计划(BX20200212,2020.06-2022.06,20万,在研)

3)2020年国自然青年科学基金项目(82003658,24万,2021.01-2023.12,在研)

3.取得专利

4 获奖